Virtus ETF Advisers LLC Celldex Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,529 shares of CLDX stock, worth $66,259. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,529

Previous 2,485 1.77%

Holding current value

$66,259

Previous $91,000 6.59%

% of portfolio

0.04%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $1,410 - $1,960	44 Added 1.77%	2,529 $85,000
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $2,817 - $3,660	86 Added 3.58%	2,485 $91,000
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $5,705 - $8,404	-162 Reduced 6.33%	2,399 $100,000
Q4 2023 Feb 15, 2024	SELL	$22.61 - $40.65 $1,582 - $2,845	-70 Reduced 2.66%	2,561 $101,000
Q3 2023 Nov 07, 2023	SELL	$25.45 - $37.46 $6,642 - $9,777	-261 Reduced 9.02%	2,631 $72,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $11,479 - $14,508	379 Added 15.08%	2,892 $98,000
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $33,632 - $45,864	-967 Reduced 27.79%	2,513 $90,000
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $37,975 - $62,034	-1,367 Reduced 28.2%	3,480 $155,000
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $703 - $1,164	31 Added 0.64%	4,847 $136,000
Q2 2022 Aug 12, 2022	BUY	$20.5 - $37.33 $14,042 - $25,571	685 Added 16.58%	4,816 $130,000
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $6,937 - $9,869	-251 Reduced 5.73%	4,131 $141,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $124,273 - $195,988	-3,483 Reduced 44.28%	4,382 $169,000
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $12,593 - $24,355	-435 Reduced 5.24%	7,865 $425,000
Q2 2021 Aug 10, 2021	SELL	$20.71 - $35.37 $169,076 - $288,760	-8,164 Reduced 49.59%	8,300 $278,000
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $4,695 - $8,673	290 Added 1.79%	16,464 $339,000
Q4 2020 Feb 12, 2021	BUY	$14.99 - $22.75 $242,448 - $367,958	16,174 New	16,174 $283,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Celldex Therapeutics, Inc. Transaction History